DK1520860T3 - Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf - Google Patents

Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf

Info

Publication number
DK1520860T3
DK1520860T3 DK04030675.5T DK04030675T DK1520860T3 DK 1520860 T3 DK1520860 T3 DK 1520860T3 DK 04030675 T DK04030675 T DK 04030675T DK 1520860 T3 DK1520860 T3 DK 1520860T3
Authority
DK
Denmark
Prior art keywords
pilc
protein
section
sequence
activity
Prior art date
Application number
DK04030675.5T
Other languages
English (en)
Inventor
Thomas F Meyer
Thomas Rudel
Roland Richard Ryll
Ina Scheuerpflug
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK1520860T3 publication Critical patent/DK1520860T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK04030675.5T 1993-10-26 1994-10-25 Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf DK1520860T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4336530A DE4336530C1 (de) 1993-10-26 1993-10-26 Rekombinante PilC-Proteine, Verfahren zu ihrer Herstellung und ihre Verwendung
EP94930216A EP0725792B1 (de) 1993-10-26 1994-10-25 VERFAHREN ZUR HERSTELLUNG REKOMBINANTER PilC-PROTEINE

Publications (1)

Publication Number Publication Date
DK1520860T3 true DK1520860T3 (da) 2013-03-11

Family

ID=6501065

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04030675.5T DK1520860T3 (da) 1993-10-26 1994-10-25 Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf

Country Status (9)

Country Link
US (1) US6268171B1 (da)
EP (2) EP0725792B1 (da)
JP (1) JP3742101B2 (da)
AT (1) ATE286069T1 (da)
AU (1) AU7939894A (da)
DE (2) DE4336530C1 (da)
DK (1) DK1520860T3 (da)
ES (2) ES2402413T3 (da)
WO (1) WO1995011919A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534579C2 (de) * 1995-09-18 2000-06-08 Max Planck Gesellschaft Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln
KR100228768B1 (ko) * 1996-10-02 1999-11-01 김영환 화학 기상증착 장치 및 증착방법
WO2001087233A2 (en) * 2000-05-16 2001-11-22 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
GB0212666D0 (en) * 2002-05-31 2002-07-10 Secr Defence Immunogenic sequences
ES2387215T3 (es) * 2003-12-23 2012-09-18 Nationwide Children's Hospital, Inc. Pili de tipo IV de la Haemophilus influenzae
GB0511722D0 (en) * 2005-06-08 2005-07-13 Secr Defence Live and subunit vaccines
US7811591B2 (en) * 2005-07-08 2010-10-12 Nationwide Children's Hospital, Inc. Chimeric vaccine for haemophilus influenzae-induced disease
WO2007028985A2 (en) * 2005-09-07 2007-03-15 The Secretary Of State For Defence Adjuvanted vaccine
EP2040744B1 (en) 2006-07-25 2016-03-09 The Secretary of State for Defence Live vaccine strains of francisella
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
HK1205138A1 (en) * 2012-07-27 2015-12-11 Institut National De La Santé Et De La Recherche Médicale (Inserm) Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
US9855326B2 (en) 2013-03-08 2018-01-02 Research Institute At Nationwide Children's Hospital Transcutaneous haemophilus influenzae vaccine formulations and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1411492A (en) * 1991-01-31 1992-09-07 Washington University Polypeptides and polynucleotides useful for the diagnosis and treatment of pathogenic neisseria
US5834591A (en) * 1991-01-31 1998-11-10 Washington University Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin
AU5403594A (en) * 1992-10-07 1994-04-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Pilin variants and uses thereof

Also Published As

Publication number Publication date
ES2235163T3 (es) 2005-07-01
US6268171B1 (en) 2001-07-31
EP1520860B1 (de) 2013-01-23
JP3742101B2 (ja) 2006-02-01
DE4336530C1 (de) 1995-04-13
DE59410401D1 (de) 2005-02-03
ES2402413T3 (es) 2013-05-03
WO1995011919A3 (de) 1995-07-13
AU7939894A (en) 1995-05-22
JPH09507745A (ja) 1997-08-12
ATE286069T1 (de) 2005-01-15
EP1520860A2 (de) 2005-04-06
EP1520860A3 (de) 2005-12-21
EP0725792B1 (de) 2004-12-29
WO1995011919A2 (de) 1995-05-04
EP0725792A1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
CS9100531A2 (en) Dna fragment that codes polypeptide with nitrile-hydratation activity,transformant that contains this gene and method of amides preparation with this transformant application
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
RU95117238A (ru) Нуклеиновая кислота, рекомбинантная плазмида, рекомбинантный вектор, белок, синтетический пептид, химерная молекула, иммуногенная композиция, антисыворотка или антитела
ATE286069T1 (de) Verfahren zur herstellung rekombinanter pilc- proteine
AU2001255250A1 (en) Cell cycle stress-related proteins and methods of use in plants
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
DE3650645D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
NO180239C (no) Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
DE69232544D1 (de) Vitamin-k-abhängige carboxylase
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
DE69132813D1 (de) Genetisches igfbp-5 rodierendes material
IL99079A0 (en) Protein structure of the plant toxin gelonin
MD20000034A (ro) Proteinele virusului răsucirii frunzelor de viţă de vie (tipul 2) şi utilizarea lor
DE69233155D1 (de) Insulinartigen wachstumsfaktor bindendes protein
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
DE69633179D1 (de) Transferrinrezeptorgene
EP2177606A3 (fr) N-désoxyribosyltransferases de lactobacilles, séquences nucléotidiques correspondantes et leurs applications
NZ501124A (en) cDNA clones of the RSPaV viral strain and associated polypeptides and antibodies thereof
Garber et al. Isolation of the proteolytically modified elongation factor G from Thermus thermophilus HB 8.
ATE154074T1 (de) Verfahren zur herstellung und reinigung des carboxyterminalen fragments der dna-polymerase i von streptococcus pneumoniae
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО
RU99127322A (ru) Белки, связывающиеся с сахарозой